ArticleBMJ oncology2024

Machine learning predicted fast progression after initiation of immune checkpoint inhibitors in advanced non-small cell lung cancer.

Yu Yang Soon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.